Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stocker

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Australian Prescriber|June 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and howSophie L Stocker, Thomas M Polasek
The European Respiratory Journal|August 31, 2023
Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and developmentSophie L Stocker, Jan-Willem C Alffenaar
Chembiochem : a European Journal of Chemical Biology|June 20, 2013
Chemical tools for studying the biological function of glycolipidsBridget L Stocker, Mattie S M Timmer
Carbohydrate Research|October 1, 2013
Trehalose diesters, lipoteichoic acids and α-GalCer: using chemistry to understand immunologyBridget L Stocker, Mattie S M Timmer
Journal of the American Chemical Society|March 16, 2006
Total synthesis of phosphatidylinositol mannosides of Mycobacterium tuberculosisXinyu Liu, Bridget L Stocker, Peter H Seeberger
The Journal of Organic Chemistry|October 10, 2006
Synthesis of a core arabinomannan oligosaccharide of Mycobacterium tuberculosisAlexandra Hölemann, Bridget L Stocker, Peter H Seeberger
Journal of Experimental Psychology. Learning, Memory, and Cognition|May 23, 2002
When debiasing backfires: accessible content and accessibility experiences in debiasing hindsightLawrence J Sanna, Norbert Schwarz, Shevaun L Stocker
Clinical Pharmacokinetics|April 4, 2024
Comment on "Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies" and "High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints"Leping Kong, Jan-Willem C Alffenaar, Sophie L Stocker
The British Journal of Oral & Maxillofacial Surgery|May 24, 2005
Is the two week rule of any benefit to patients with oral cancer?S C East, J L Stocker, B S Avery
The Journal of Infectious Diseases|March 30, 2026
Does one dose fit all in tuberculosis meningitis treatment?Jan-Willem C Alffenaar, Sophie L Stocker, Thomas Schön
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Australian Prescriber|June 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and howSophie L Stocker, Thomas M Polasek
The European Respiratory Journal|August 31, 2023
Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and developmentSophie L Stocker, Jan-Willem C Alffenaar
Chembiochem : a European Journal of Chemical Biology|June 20, 2013
Chemical tools for studying the biological function of glycolipidsBridget L Stocker, Mattie S M Timmer
Carbohydrate Research|October 1, 2013
Trehalose diesters, lipoteichoic acids and α-GalCer: using chemistry to understand immunologyBridget L Stocker, Mattie S M Timmer
Journal of the American Chemical Society|March 16, 2006
Total synthesis of phosphatidylinositol mannosides of Mycobacterium tuberculosisXinyu Liu, Bridget L Stocker, Peter H Seeberger
The Journal of Organic Chemistry|October 10, 2006
Synthesis of a core arabinomannan oligosaccharide of Mycobacterium tuberculosisAlexandra Hölemann, Bridget L Stocker, Peter H Seeberger
Journal of Experimental Psychology. Learning, Memory, and Cognition|May 23, 2002
When debiasing backfires: accessible content and accessibility experiences in debiasing hindsightLawrence J Sanna, Norbert Schwarz, Shevaun L Stocker
Clinical Pharmacokinetics|April 4, 2024
Comment on "Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies" and "High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints"Leping Kong, Jan-Willem C Alffenaar, Sophie L Stocker
The British Journal of Oral & Maxillofacial Surgery|May 24, 2005
Is the two week rule of any benefit to patients with oral cancer?S C East, J L Stocker, B S Avery
The Journal of Infectious Diseases|March 30, 2026
Does one dose fit all in tuberculosis meningitis treatment?Jan-Willem C Alffenaar, Sophie L Stocker, Thomas Schön
Pageof 22